Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · IEX Real-Time Price · USD
2.550
-0.100 (-3.77%)
At close: Apr 25, 2024, 4:00 PM
2.580
+0.030 (1.18%)
After-hours: Apr 25, 2024, 4:49 PM EDT

Heron Therapeutics Market Cap

Heron Therapeutics has a market cap or net worth of $383.34 million as of April 25, 2024. Its market cap has increased by 19.94% in one year.

Market Cap
383.34M
Enterprise Value
482.56M
1-Year Change
19.94%
Ranking
Category
Stock Price
$2.55

Market Cap Chart

Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $383.34M, an increase of 200.89%. That is a compound annual growth rate of 4.43%.

History

DateMarket Cap% Change
Apr 24, 2024398.40M-5.35%
Apr 23, 2024420.90M8.09%
Apr 22, 2024389.40M-1.89%
Apr 19, 2024396.90M-2.58%
Apr 18, 2024407.40M-2.16%
Apr 17, 2024416.40M-5.47%
Apr 16, 2024440.50M-0.68%
Apr 15, 2024443.50M1.37%
Apr 12, 2024437.50M-1.02%
Apr 11, 2024442.00M7.70%
Apr 10, 2024410.40M-2.49%
Apr 9, 2024420.90M1.81%
Apr 8, 2024413.40M-
Apr 5, 2024413.40M7.02%
Apr 4, 2024386.30M-
Apr 3, 2024386.30M0.78%
Apr 2, 2024383.30M-5.92%
Apr 1, 2024407.40M-2.16%
Mar 28, 2024416.40M1.09%
Mar 27, 2024411.90M-
Mar 26, 2024411.90M-7.13%
Mar 25, 2024443.50M-0.67%
Mar 22, 2024446.50M-2.62%
Mar 21, 2024458.50M-
Mar 20, 2024458.50M3.38%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Humacyte 474.85M
Taysha Gene Therapies 474.09M
Nevro 465.71M
Acelyrin 464.31M
Editas Medicine 463.80M
Fulcrum Therapeutics 462.04M
Theravance Biopharma 458.05M
IGM Biosciences 455.66M
Market Cap Rankings